Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • immunotherapy

    Tag: immunotherapy

    You Searched For "immunotherapy"
    Tecentriq-Avastin cocktail helps liver cancer patients live longer: Roche

    Tecentriq-Avastin cocktail helps liver cancer patients live longer: Roche

    Medical Dialogues Bureau25 Nov 2019 9:00 AM IST
    Median overall survival for patients with unresectable hepatocellular carcinoma (HCC), or that which cannot be surgically removed, getting Tecentriq...
    Roche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCC

    Roche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCC

    Medical Dialogues Bureau22 Oct 2019 9:50 AM IST
    Roche, in its recent release, in 2018, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) for Tecentriq in...
    Bristol-Myers blockbuster Opdivo fails to meet goal of brain tumour study

    Bristol-Myers blockbuster Opdivo fails to meet goal of brain tumour study

    Medical Dialogues Bureau8 Sept 2019 9:15 AM IST
    The drug, Opdivo, when used along with the current standard of care for glioblastoma multiforme, did not prevent cancer from spreading when compared...
    GSK Belantamab Mafodotin shows to help blood cancer patients

    GSK Belantamab Mafodotin shows to help blood cancer patients

    Medical Dialogues Bureau26 Aug 2019 9:15 AM IST
    Two doses of Belantamab Mafodotin helped subdue the disease in adults who had received three prior treatments for multiple myeloma, a cancer of the...
    Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel

    Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel

    Medical Dialogues Bureau28 July 2019 9:17 AM IST
    Sales of Eliquis, which Bristol-Myers shares with Pfizer Inc (PFE.N), rose 24% to $2.04 billion, while Orencia sales rose 9% to $778 million, both...
    GSK drug Zejula helps ovarian cancer patients live longer in late-stage study

    GSK drug Zejula helps ovarian cancer patients live longer in late-stage study

    Medical Dialogues Bureau16 July 2019 9:26 AM IST
    GSK bought the drug when it acquired U.S. cancer specialist Tesaro for $5.1 billion in December and Zejula is already approved for certain ovarian...
    Sandoz launches SYMJEPI Injection in US to help treat allergic reactions

    Sandoz launches SYMJEPI Injection in US to help treat allergic reactions

    Medical Dialogues Bureau13 July 2019 9:32 AM IST
    SYMJEPI is a small, single-dose, pre-filled syringe and device combination as an alternative to epinephrine auto-injectors for the emergency treatment...
    Merck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancer

    Merck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancer

    Medical Dialogues Bureau12 Jun 2019 9:50 AM IST
    The approval is based on results from a late-stage trial, where Keytruda showed a significant improvement in overall survival in cancer patients,...
    AstraZeneca Q1 sales beat estimates on cancer drugs

    AstraZeneca Q1 sales beat estimates on cancer drugs

    Garima28 April 2019 9:15 AM IST
    AstraZeneca, fresh off an oncology deal with Japan's Daiichi Sankyo Co Ltd, in February reported annual sales growth for the first time since 2009,...
    Novartis CAR-T therapy leads to durable response in lymphoma study

    Novartis CAR-T therapy leads to durable response in lymphoma study

    Ruby Khatun Khatun11 Dec 2017 10:45 AM IST
    Patients with an advanced form of an aggressive blood cancer who had initially responded to Novartis' new type of gene-modifying immunotherapy...
    More than 2,000 drugs now in cancer immunotherapy race

    More than 2,000 drugs now in cancer immunotherapy race

    Ruby Khatun Khatun9 Dec 2017 10:00 AM IST
    LONDON: The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with...
    Roche drug cocktail doubles chance of holding lung cancer at bay

    Roche drug cocktail doubles chance of holding lung cancer at bay

    Ruby Khatun Khatun9 Dec 2017 9:45 AM IST
    ZURICH: Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok